glp-1 dementia study Frontiers GLP-1 Dementia, Alzheimer's Disease Risks

doi: 10.1111/dom.16660

However, while the clinical results with semaglutide support indications for treatment of obesity per s (Wegovy R ) as well as T2D (Ozempic R ), weight reduction with these agents remains considerably less than the best surgical results, and is often only a fraction of what most patients require for correction of the co-morbidities of increased body weight

10.1016/j.molmet.2013.12.001 116

Knowing how to maximize those benefits is actionable

Ahmad K, Baig MH, Mushtaq G, Kamal MA, Greig NH, Choi I

[DOI] [PMC free article] [PubMed] [Google Scholar] 22.Kharitonenkov A., Shiyanova T.L., Koester A., Ford A.M., Micanovic R., Galbreath E.J., et al